# Mineralys Therapeutics, Inc.: filings

MLYS · Nasdaq · CIK 1933414 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mlys.md) · [Financials](/companies/mlys/financials.md) · [Filings](/companies/mlys/filings.md) · [Insiders](/companies/mlys/insiders.md)

## Reports and events: 76 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 162, 144 94, 8-K 48, 3 18, 10-Q 11, 424B5 6, SC 13G 5, SCHEDULE 13G/A 5, 10-K 4, S-8 4, SCHEDULE 13D/A 4, ARS 3, CORRESP 3, DEF 14A 3, DEFA14A 3, SC 13G/A 3, UPLOAD 3, DRS/A 2, DRSLTR 2, EFFECT 2, SC 13D 2, SC 13D/A 2, SEC STAFF LETTER 2, 144/A 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DRS 1, S-1 1, S-1/A 1, S-1MEF 1, S-3 1, S-3/A 1, S-3ASR 1, S-3MEF 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:08 ET | [8-K](/filings/0001933414-26-000136.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001933414-26-000136 |
| 2026-10-19 | 16:37 ET | [8-K](/filings/0001933414-26-000125.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001933414-26-000125 |
| 2026-08-11 | 17:18 ET | [10-Q](/filings/0001933414-26-000114.md) | Quarterly report, period 2026-06-30 | 0001933414-26-000114 |
| 2026-08-11 | 16:08 ET | [8-K](/filings/0001933414-26-000112.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001933414-26-000112 |
| 2026-06-03 | 16:07 ET | [8-K](/filings/0001628280-26-040225.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-040225 |
| 2026-06-03 | 06:02 ET | [8-K](/filings/0001628280-26-040024.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001628280-26-040024 |
| 2026-05-22 | 16:50 ET | [8-K](/filings/0001933414-26-000090.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001933414-26-000090 |
| 2026-05-06 | 17:15 ET | [10-Q](/filings/0001933414-26-000084.md) | Quarterly report, period 2026-03-31 | 0001933414-26-000084 |
| 2026-05-06 | 16:07 ET | [8-K](/filings/0001933414-26-000082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-26-000082 |
| 2026-04-08 | 08:47 ET | [DEF 14A](/filings/0001933414-26-000069.md) | Proxy statement, period 2026-05-21 | 0001933414-26-000069 |
| 2026-03-12 | 17:19 ET | [10-K](/filings/0001933414-26-000056.md) | Annual report, period 2025-12-31 | 0001933414-26-000056 |
| 2026-03-12 | 16:08 ET | [8-K](/filings/0001933414-26-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-26-000054 |
| 2026-03-09 | 16:36 ET | [8-K](/filings/0001933414-26-000048.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-26-000048 |
| 2026-01-06 | 08:05 ET | [8-K](/filings/0001933414-26-000002.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-26-000002 |
| 2025-11-10 | 17:11 ET | [10-Q](/filings/0001933414-25-000142.md) | Quarterly report, period 2025-09-30 | 0001933414-25-000142 |
| 2025-11-10 | 16:06 ET | [8-K](/filings/0001933414-25-000139.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-25-000139 |
| 2025-09-08 | 20:05 ET | [SCHEDULE 13D/A](/filings/0001415889-25-023916.md) | Ownership report, active investor, amended | 0001415889-25-023916 |
| 2025-09-08 | 18:00 ET | [SCHEDULE 13D/A](/filings/0001415889-25-023895.md) | Ownership report, active investor, amended | 0001415889-25-023895 |
| 2025-09-03 | 16:02 ET | [8-K](/filings/0001933414-25-000120.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-25-000120 |
| 2025-09-02 | 17:00 ET | [8-K](/filings/0001933414-25-000107.md) | 8.01 Other events | 0001933414-25-000107 |
| 2025-08-12 | 17:20 ET | [10-Q](/filings/0001933414-25-000090.md) | Quarterly report, period 2025-06-30 | 0001933414-25-000090 |
| 2025-08-12 | 16:06 ET | [8-K](/filings/0001933414-25-000088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-25-000088 |
| 2025-06-17 | 07:07 ET | [8-K](/filings/0001933414-25-000070.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-25-000070 |
| 2025-05-22 | 16:14 ET | [8-K](/filings/0001933414-25-000064.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001933414-25-000064 |
| 2025-05-12 | 17:31 ET | [10-Q](/filings/0001933414-25-000058.md) | Quarterly report, period 2025-03-31 | 0001933414-25-000058 |
| 2025-05-12 | 16:13 ET | [8-K](/filings/0001933414-25-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-25-000057 |
| 2025-04-09 | 08:16 ET | [DEF 14A](/filings/0001933414-25-000036.md) | Proxy statement, period 2025-05-22 | 0001933414-25-000036 |
| 2025-03-31 | 08:15 ET | [8-K](/filings/0001933414-25-000026.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-25-000026 |
| 2025-03-17 | 21:06 ET | [SCHEDULE 13D/A](/filings/0001415889-25-008276.md) | Ownership report, active investor, amended | 0001415889-25-008276 |
| 2025-03-17 | 19:58 ET | [SCHEDULE 13D/A](/filings/0001415889-25-008259.md) | Ownership report, active investor, amended | 0001415889-25-008259 |
| 2025-03-12 | 16:02 ET | [8-K](/filings/0001628280-25-012335.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-012335 |
| 2025-03-10 | 07:05 ET | [8-K](/filings/0001628280-25-011459.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-011459 |
| 2025-02-12 | 09:22 ET | [10-K](/filings/0001933414-25-000009.md) | Annual report, period 2024-12-31 | 0001933414-25-000009 |
| 2025-02-12 | 07:07 ET | [8-K](/filings/0001933414-25-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-25-000008 |
| 2025-02-04 | 08:05 ET | [8-K](/filings/0001933414-25-000006.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-25-000006 |
| 2025-01-08 | 08:07 ET | [8-K](/filings/0001933414-25-000002.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-25-000002 |
| 2024-11-12 | 08:36 ET | [10-Q](/filings/0001933414-24-000057.md) | Quarterly report, period 2024-09-30 | 0001933414-24-000057 |
| 2024-11-12 | 08:32 ET | [8-K](/filings/0001933414-24-000056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-24-000056 |
| 2024-10-30 | 08:03 ET | [8-K](/filings/0001933414-24-000050.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-24-000050 |
| 2024-09-25 | 08:06 ET | [8-K](/filings/0001933414-24-000044.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-24-000044 |
| 2024-08-13 | 16:10 ET | [10-Q](/filings/0001933414-24-000039.md) | Quarterly report, period 2024-06-30 | 0001933414-24-000039 |
| 2024-08-13 | 16:07 ET | [8-K](/filings/0001933414-24-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-24-000038 |
| 2024-06-14 | 08:06 ET | [8-K](/filings/0001933414-24-000028.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001933414-24-000028 |
| 2024-06-10 | 16:02 ET | [8-K](/filings/0001933414-24-000025.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001933414-24-000025 |
| 2024-05-31 | 16:06 ET | [8-K](/filings/0001933414-24-000024.md) | 9.01 Financial statements and exhibits | 0001933414-24-000024 |
| 2024-05-22 | 16:38 ET | [8-K](/filings/0001933414-24-000017.md) | 5.07 Shareholder vote results | 0001933414-24-000017 |
| 2024-05-09 | 07:10 ET | [10-Q](/filings/0001933414-24-000016.md) | Quarterly report, period 2024-03-31 | 0001933414-24-000016 |
| 2024-05-09 | 07:07 ET | [8-K](/filings/0001933414-24-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001933414-24-000015 |
| 2024-04-09 | 07:15 ET | [DEF 14A](/filings/0001933414-24-000009.md) | Proxy statement, period 2024-04-09 | 0001933414-24-000009 |
| 2024-04-04 | 08:04 ET | [8-K](/filings/0001933414-24-000008.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001933414-24-000008 |

Page 1 of 2. [Older](/companies/mlys/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:10 ET. No prices; not investment advice.